Literature DB >> 28194727

Review of Cardiovascular Imaging in the Journal of Nuclear Cardiology in 2016. Part 1 of 2: Positron Emission Tomography, Computed Tomography and Magnetic Resonance.

Wael AlJaroudi1, Fadi G Hage2,3.   

Abstract

Several original articles and editorials have been published in the Journal of Nuclear Cardiology last year. It has become a tradition at the beginning of each year to summarize some of these key articles (AlJaroudi and Hage in J Nucl Cardiol 22:507-512, 2015, 23:122-130, 2016; Hage and AlJaroudi in J Nucl Cardiol 22:714-719, 2015; 23:493-498, 2016). In this part one, we will discuss some of the progress made in patients with infiltrative disease, cardiomyopathies (non-ischemic, ischemic, and diabetic), hybrid and molecular imaging, using advancement in positron emission tomography, computed tomography, and magnetic resonance imaging.

Entities:  

Keywords:  CMR; CT; PET; Review; cardiovascular imaging

Mesh：

Year:  2017        PMID： 28194727     DOI： 10.1007/s12350-017-0820-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


  38 in total

1.  Molecular cardiovascular imaging is ready for prime time: almost there.

Authors:  Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

2.  Assessment of left ventricular ejection fraction using low radiation dose computed tomography.

Authors:  YiQi Yang; Yeung Yam; Li Chen; Ahmed Aljizeeri; Siamak Aliyary Ghraboghly; Ibraheem Al-Harbi; Ally Pen; Terrence D Ruddy; Benjamin J W Chow
Journal:  J Nucl Cardiol       Date:  2015-05-22       Impact factor: 5.952

3.  Methods for evaluating the agreement between diagnostic tests.

Authors:  Charity J Morgan; Inmaculada Aban
Journal:  J Nucl Cardiol       Date:  2015-05-21       Impact factor: 5.952

4.  Analysis of the 17-segment left ventricle model using generalized estimating equations.

Authors:  Samantha R Seals; Inmaculada B Aban
Journal:  J Nucl Cardiol       Date:  2015-06-02       Impact factor: 5.952

5.  The good, bad, and ugly of incidental findings on cardiovascular-computed tomography.

Authors:  Pradeep Bhambhvani
Journal:  J Nucl Cardiol       Date:  2015-07-24       Impact factor: 5.952

6.  Quantitative molecular imaging of cardiac amyloidosis: The journey has begun.

Authors:  Sharmila Dorbala; Marie Foley Kijewski; Mi-Ae Park
Journal:  J Nucl Cardiol       Date:  2015-07-16       Impact factor: 5.952

7.  The reproducibility of time-of-flight PET and conventional PET for the quantification of myocardial blood flow and coronary flow reserve with (13)N-ammonia.

Authors:  Masaya Suda; Masahisa Onoguchi; Takeshi Tomiyama; Keiichi Ishihara; Naoto Takahashi; Minoru Sakurai; Keiichi Matsumoto; Shin-Ichiro Kumita
Journal:  J Nucl Cardiol       Date:  2015-03-17       Impact factor: 5.952

8.  The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy.

Authors:  Ankur Gulati; Tevfik F Ismail; Andrew Jabbour; Francisco Alpendurada; Kaushik Guha; Nizar A Ismail; Sadaf Raza; Jahanzaib Khwaja; Tristan D H Brown; Kishen Morarji; Emmanouil Liodakis; Michael Roughton; Ricardo Wage; Tapesh C Pakrashi; Rakesh Sharma; John-Paul Carpenter; Stuart A Cook; Martin R Cowie; Ravi G Assomull; Dudley J Pennell; Sanjay K Prasad
Journal:  Circulation       Date:  2013-08-21       Impact factor: 29.690

9.  Comparison of stress cardiovascular magnetic resonance imaging (CMR) with stress nuclear perfusion for the diagnosis of coronary artery disease.

Authors:  Ijaz G Ahmad; Raushan K Abdulla; Igor Klem; Roman Margulis; Alexander Ivanov; Ambreen Mohamed; Robert M Judd; Salvatore Borges-Neto; Raymond J Kim; John F Heitner
Journal:  J Nucl Cardiol       Date:  2015-08-13       Impact factor: 5.952

10.  The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis.

Authors:  Osamu Manabe; Keiichiro Yoshinaga; Hiroshi Ohira; Atsuro Masuda; Takahiro Sato; Ichizo Tsujino; Asuka Yamada; Noriko Oyama-Manabe; Kenji Hirata; Masaharu Nishimura; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2015-08-05       Impact factor: 5.952
View more
  5 in total

1.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2018. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2019-01-02       Impact factor: 5.952

Review 2.  Review of cardiovascular imaging in the journal of nuclear cardiology in 2016: Part 2 of 2-myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2017-04-06       Impact factor: 5.952

Review 3.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-11-08       Impact factor: 5.952

Review 4.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2018-04-16       Impact factor: 5.952

Review 5.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2020: positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2021-06-08       Impact factor: 5.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.